$FPH

First Phil Holdings rejects KKR bid for First Gen stake

First Philippine Holdings (FPH) said it rejected KKR’s non-binding bid to buy FPH’s 8.43% stake in First Gen and launch a voluntary tender offer for First Gen’s 11.67% public float at P35 per share. FPH said the proposal does not reflect First Gen’s true value and ended its participation. FPH shares fell P1 to P102; First Gen fell P3.50 to P27.20.

Original reporting
Published Aug 17, 2026, 4:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 17, 2026, 4:55 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
First Phil Holdings rejects KKR bid for First Gen stake — source image
Decision brief

The 30-second read

$FPHNeutralMed
01

Why it matters

FPH’s rejection states the proposal does not represent First Gen’s true value and effectively ends FPH’s participation under KKR’s terms, coinciding with declines in both FPH and First Gen shares.

02

Market read

This is a direct M&A catalyst failure for a listed Philippine power holding structure, removing a potential tender-offer premium narrative.

03

What to watch

The article provides no valuation framework or stated minimum price, so traders may be overreacting to the rejection without knowing whether KKR could return with improved terms.

Relevance 7/10Novelty 6/10Timing: today, after-hours/next-session positioning following the rejection disclosure

Background

KKR made a non-binding proposal to buy an 8.43% stake in First Gen from FPH, followed by a voluntary tender offer for First Gen’s 11.67% public float at P35 per share.

Company-level read

Ticker impact

$FPHNeutralMedium confidence
Context

First Philippine Holdings rejected KKR’s non-binding proposal to buy part of its First Gen stake and end its participation in the deal terms.

Expected impact

Near-term downside bias versus a scenario where the bid progressed; magnitude likely limited to deal-spillover sentiment.

Evidence & confidence

The article is a direct corporate action update (deal rejection) with same-day share weakness, but it provides no alternative valuation or new strategic plan.

Market effects

Signals reduced M&A/tender-offer appetite in Philippine power holdings, potentially lowering takeover-premium expectations for similar structures.

May weigh on Philippine market sentiment around corporate actions involving listed infrastructure/power assets.

Limited, as the transaction is localized and non-binding with no confirmed alternative bidder in the article.

Counterpoint

FPH’s rejection could be tactical, preserving optionality for a higher bid later, which may reduce the durability of the immediate selloff.

Key entities

  • First Philippine Holdings Corp.

    FPH rejected KKR’s non-binding proposal to acquire part of its First Gen stake.

  • Kohlberg Kravis Roberts & Co. L.P.

    KKR proposed to buy FPH’s 8.43% stake and launch a tender offer at P35 per share.

  • First Gen Corp.

    FGEN’s shares dropped after the rejection ended the proposed transaction under KKR’s terms.

Related articles

$FPHMed

Five Point Q3 Earnings Call Highlights

Five Point (FPH) expects small Q4 net income and $20M for 2026, adjusting land sale expectations. Q3 saw 54 homes sold at Great Park, 92 at Valencia. Cash position: $358.7M, liquidity: $576.2M. CFO Tobler forecasts >$300M cash by 2026, with $125M development spending planned. Management revenue: $13.9M, Hearthstone AUM: $3.4B. Progress reported at Valencia and Candlestick.

$FPHMed

Five Point Holdings, LLC Reports Third Quarter 2026 Results

Five Point Holdings, LLC (FPH) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Five Point Holdings, LLC Reports Third Quarter 2026 Results Third Quarter 2026 Highlights • Great Park Venture distributions and incentive compensation payments to the Company totaled $40.4 million. • Great Park builder sales of 54 homes during the quarter. • Valenci

$RMDMed

CSL, Resmed, and more. See which ASX health stocks RBC Capital Markets has upgraded

RBC Capital Markets upgraded five ASX-listed healthcare stocks to outperform, citing positive earnings growth and attractive valuations. CSL (ASX: CSL) was highlighted for market share gains, with a $213 price target. ResMed (ASX: RMD) was noted for capital management, with a $262 target. Ramsay Healthcare (ASX: RHC) was praised for cost control, with a $68 target. Fisher & Paykel (ASX: FPH) showed strong growth, with a $52 target. Nanosonics (ASX: NAN) had mixed results but a $3.75 target.

$FPHMedAI 8/10

Market quiet but earnings showing positive signs

Fisher & Paykel Healthcare upgraded its 2027 guidance, citing strong hospital product sales. Revenue and net profit forecasts increased, with first-half revenue expected at $1.24B and net profit at $280M. The stock closed at $43.52. On Wall Street, the Dow fell 1.32% as bond yields rose and Walmart missed earnings. In NZ, several companies reported earnings, including South Port NZ and Seeka.

$FPHMed

FPH turns down KKR bid for First Gen stake over valuation

First Philippine Holdings (FPH) rejected KKR’s non-binding bid to buy an additional 8.43% stake in First Gen and then tender for First Gen’s public float at P36/share, saying it undervalues First Gen. FPH owns 67.84% of First Gen; KKR has 19.9% economic interest. The deal would have supported a delisting. First Gen also weighs a $5B offer from BREN for EDC.